PeptideMeter result on a Wuxi mazdutide lot lands 2.1 points above the supplier’s stated figure
The supplier confirmed the determination and supplied the method behind its own figure inside a week.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Freight
What would make a difference is not a regulator. It is three lines on a certificate, all of which are already known to whoever wrote it.
There is a structural reason this documentation does not exist, and it is worth stating before criticising anybody for its absence. A stability study takes as long as the shelf life it supports. Accelerated conditions provide early warning and, for peptides, do not reliably extrapolate, because the dominant degradation pathway at forty degrees is frequently not the dominant pathway at five. There is no instrument, no laboratory and no amount of money that produces a twenty-four-month result in under twenty-four months. What can be done cheaply is to state what has and has not been measured, and that is what we are asking for.
Every stability figure is a conditional statement, and the condition is the part that gets dropped. A twenty-four-month shelf life means twenty-four months at a specified temperature, in a specified container closure system, with a specified formulation, assessed against a specified set of acceptance criteria by methods capable of detecting the changes that matter. Remove any one of those qualifiers and the number stops being checkable.
The trade routinely reports the number and none of the qualifiers. A certificate stating a two-year shelf life without a storage condition is asserting nothing in particular, and the same document frequently carries a storage instruction that has been copied from another product. The Journal’s habit is to treat an unqualified shelf life the same way we treat an unqualified purity figure: as a decoration until the procedure behind it is disclosed.
There is also a vocabulary problem worth clearing up. An expiry date states that material should not be used beyond it. A retest date states that material should be re-examined against specification before use beyond it, and is the appropriate concept for a stable chemical entity held in a controlled environment. Research suppliers overwhelmingly print the first word while meaning something closer to the second, and readers are entitled to know which is intended.1
Retest date and expiry date are distinct concepts used interchangeably here. A retest date says material may be re-examined and used if it still conforms; an expiry says it may not. Printing one and meaning the other has become a convention rather than a decision.
Two methods dominate. Karl Fischer titration determines water specifically, by a stoichiometric reaction with iodine, and is the reference method; the coulometric variant works on the small sample masses a single vial provides. Loss on drying is simpler and less specific, measuring total volatile mass lost under defined heating, which for a formulation containing residual organic solvent overstates the water.
Typical release specifications for lyophilised peptides sit in the range of one to three per cent water by mass, with tighter limits where the molecule is particularly moisture-sensitive. The relationship to stability is not linear. Below roughly one per cent, further drying sometimes destabilises rather than helps, because a monolayer of water contributes to conformational stability in some solid-state systems. Above three per cent, deamidation and hydrolysis rates rise steeply and the glass transition falls towards ambient.
Residual moisture is nowhere a routine line on a research-grade certificate; each of the twenty companies the Journal tracks will quote for it on request, and none of them prints it unasked. Two will provide a figure on request. This is the omission we would most like to see closed, ahead of endotoxin and well ahead of anything else, for a straightforwardly practical reason: it is a cheap determination on a small sample, it is performed in any pharmaceutical analytical laboratory, and it predicts what the vial will be like in eighteen months better than the purity figure that is printed instead.
The aggregate arrives at the column, comes apart, and is recorded as monomer.
Callum Brathwaite, Analytical Chemistry CorrespondentA stability study is only as good as the analytical method behind it, and the requirement has a name: the method must be stability-indicating, meaning it must resolve the parent compound from its degradation products and quantify the change. Establishing that is done by forced degradation — deliberately stressing the material with acid, base, oxidant, heat and light — and demonstrating that the resulting products are separated from the parent and from each other with adequate peak purity.
Almost nothing sold as a purity determination in this market has been validated that way. A generic peptide gradient run for twelve minutes may perfectly well resolve the parent from its two largest process impurities and entirely fail to resolve it from its isoaspartate isomer or a closely related oxidation product. The number it returns is a purity figure, not a stability measurement, and using a series of such figures to argue that a product has not degraded is a category error.
The compendial guidance on analytical validation is explicit about specificity, and about demonstrating it against the degradation products the molecule can actually form. The gap between that expectation and practice in this trade is not a matter of dishonesty. It is that the method being sold was designed for a different purpose and is being asked a question it was not built to answer.2
| Documented item | Companies reporting as standard | On request | Not available |
|---|---|---|---|
| Storage condition, lyophilised | 20 | 0 | 0 |
| Storage condition stated separately for reconstituted | 6 | 3 | 11 |
| Shelf life or retest interval | 19 | 0 | 1 |
| Residual moisture | 0 | 2 | 18 |
| Study conditions supporting the shelf life | 0 | 1 | 19 |
| In-use period from a study on that product | 0 | 0 | 20 |
| Compiled from the standard release documentation of twenty companies tracked by the Journal, supplemented by a written questionnaire sent twice, four weeks apart. On request denotes a documented instance of the item being supplied when asked. The final row is the one we would most like to be able to revise. | |||
The harmonised guideline defines the conditions under which stability data must be generated for registration, and they are worth knowing because they are the vocabulary any serious stability claim will use. For a product intended for storage at room temperature, long-term testing runs at twenty-five degrees and sixty per cent relative humidity, or thirty degrees and sixty-five per cent in hotter climatic zones, for at least twelve months. Accelerated testing runs at forty degrees and seventy-five per cent humidity for six months.
For a product intended for refrigerated storage, long-term testing runs at five degrees plus or minus three, and the accelerated condition becomes twenty-five degrees at sixty per cent humidity. Significant change at the accelerated condition triggers testing at an intermediate condition. A product intended for frozen storage is tested long-term at minus twenty, and because accelerated testing is not meaningful there, the guidance instead requires a single-batch study of the effect of a short excursion above the intended condition.
That last provision is the interesting one for this trade, because a frozen-storage product with no excursion data has no basis for any statement about what a warm afternoon in transit did to it. Biotechnological products have their own parallel guidance, which additionally requires that the analytical methods be capable of detecting the degradation products characteristic of the molecule class.3
The Journal tracks release documentation from twenty companies whose names appear on labels in this market. On stability the picture is close to uniform. All twenty state a storage condition. Nineteen state a shelf life. None reports residual moisture as standard. None states whether the shelf life is supported by a study on that product, and none distinguishes a retest date from an expiry date.
Where practice differs it is worth naming. SGN and MKM state the storage condition separately for the lyophilised and reconstituted states, which is a small thing and closes a real ambiguity. KP and HJ ship in amber glass. QST provided, on request, the conditions and duration of a study on one product, and it is the model this desk now asks the rest of the twenty to follow. GGPeps, GL Biochem and Homopeptide operate primarily as chemical suppliers where a retest convention is standard practice in the wider chemical trade, and their documentation reflects that convention more accurately than the pharmaceutical framing used elsewhere. TFC, JEEP, QSC and ERP answered the questionnaire in full, and the remainder of the twenty answered the sections that applied to their own operations.
The criticism, again, is of a documentary convention rather than of anybody’s conduct. No company named here has been shown to us to have misstated a result. What we are describing is a set of copied storage phrases standing in for measurements that mostly have not been made, and a market that has never been asked to distinguish the two.
A stated storage condition and a stability study are different things that look identical on a label. The question worth asking is not what the condition is but what data it rests on, and the answers separate this trade quite sharply.
Nobody can buy time, which is why this documentation gap is not going to be closed by a testing service. What can be done immediately is to distinguish a measurement from a convention: to say twelve months at minus twenty, ongoing, rather than two years, and to say that an in-use period has not been established for this product rather than borrowing one from a pen.
Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.
Loggers have become cheap enough that a supplier could include one in every carton for the cost of the outer box. The barrier is the willingness to generate a record that might be unflattering.
— J. Marsden-Hoyle, Halifax
The most useful thing a supplier can publish is its packing specification: pack type, quantity, insulation, and the tested hold time at a stated ambient. It is a page of text and it would let a buyer reason about their own climate.
— G. Thorbjørnsen, Tromsø
Eleven days in customs, and you describe it as a structural feature rather than a scandal. Why the restraint? A shipper advertising a cold chain that demonstrably does not survive a routine examination is making a claim it cannot support.
— G. Kalinowski, Poznań
The restraint is about where the fault lies. Customs authorities are performing a lawful function and owe nobody a thermal record. The claim of end-to-end control is the thing we criticise, and we do criticise it, in the article and again in the closing. What we will not do is convert an unavoidable feature of international freight into an allegation against the shipper who could not see it either.
The supplier confirmed the determination and supplied the method behind its own figure inside a week.
The supplier confirmed the determination and supplied the method behind its own figure inside a week.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
Follow the resin, not the catalogue.